CARUMONAM manufacturers and suppliers

CARUMONAM suppliers

CARUMONAM

CAS:: 87638-04-8

MF:: C12H14N6O10S2

MW:: 466.4

Suppliers by country/region

Company Type

Properties

alpha: D26 -45° (c = 1 in DMSO)

Density: 2.13±0.1 g/cm3(Predicted)

pka: -0.43±0.60(Predicted)

Safety Information

Use

A synthetic monobactam with activity against common pathogenic organisms similar to that of aztreonam. It is resistant to hydrolysis by the common plasmid and chromosomal β-lactamases, but it can be hydrolyzed by ESBLs. It is administered intravenously, achieving a concentration of c. 78 mg/L after a 20-min infusion of 1 g. The plasma halflife is 1.7 h and the plasma protein binding 18–28%. Carumonam is almost entirely eliminated in the glomerular filtrate, probenecid having no effect on excretion; 96% of labeled compound is found in the urine, with 3% in the feces. Between 68% and 91% of the dose appears in the urine within 24 h. Side effects and clinical use are similar to those of aztreonam.

You can find CARUMONAM suppliers, manufacturers, and distributors from countries such as CHINA, United States and the United Kingdom here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.